SAHARA+ is Back for 2026

Evidence to Impact:

Driving Saudi Healthcare Transformation

9 - 10 October 2026
Crowne Plaza RDC, Riyadh, KSA

About the Conference

Aligned with Saudi Arabia’s Vision 2030

The SAHARA+ Conference 2026, under the theme "Evidence to Impact: Driving Saudi Healthcare Transformation", is a premier strategic platform dedicated to advancing sustainable healthcare transformation in the Kingdom. It reflects the country’s ongoing shift toward a value-based, patient-centered, innovation-driven, and financially sustainable healthcare system.

SAHARA+ brings together healthcare policymakers, regulators, HTA experts, payers, providers, and industry leaders to translate evidence into real-world impact. The conference focuses on Health Technology Assessment (HTA), evidence-based decision-making, regulatory excellence, value-based healthcare, and sustainable financing models, alongside market access, digital health, and healthcare innovation.

A strong emphasis is placed on specialty pharmaceuticals evaluation, clinical trends, resource utilization management, pharmacoeconomics, and real-world evidence to ensure optimal healthcare value and system efficiency.

The agenda addresses key therapeutic areas and national priorities, including Oncology, Rare Diseases, and Cardiometabolic Disorders, among other high-burden diseases. Ultimately, SAHARA+ aims to strengthen healthcare sustainability, improve patient access and outcomes, and accelerate data-driven decision-making across Saudi Arabia’s evolving healthcare ecosystem.

Key Area Focus

  • Healthcare Transformation & System Sustainability

  • Health Technology Assessment (HTA) & Evidence-Based Decision Making

  • Specialty Pharmaceuticals Evaluation & Clinical Value Optimization

  • Sustainable Funding, Value-Based Healthcare & Resource Utilization Management

  • Regulatory Excellence, Market Access & Policy Innovati

  • Innovation, Digital Health & Data-Driven Healthcare

  • Patient Outcomes, Population Health & Therapeutic Area Focus

    (Oncology, Rare Disease & Other High-burden disease)

Target Audience

  • Regulatory Authorities

  • Pharmacists

  • Pharmacoeconomics /Health Economists

  • Hospital Executives and Healthcare Administrators

  • Clinicians and Key Opinion Leaders

  • Health Technology Assessment (HTA) Specialists

  • Payers & Health Insurance – Drug Pricing & Reimbursement Departments

  • Real-World Evidence (RWE) and Real-World Data (RWD) Experts

  • HEOR (Health Economics & Outcomes Research) Professionals

  • Digital Health and health technology innovators

  • Pharma Industry: Market Access Team

Steering Committee

Conference Chairman

Ahmed Aljedai

Founding President, Saudi Society of Clinical Pharmacy

Professor, Colleges of Medicine and Pharmacy, Alfaisal University

Consultant Clinical Pharmacist, Solid Organ Transplant, KSA

Conference Vice Chair

Mohammed Alshennawi

General Director

General Administration of Pharmaceutical Care

Ministry of Health, KSA

Organizing Committee Chair

Wejdan Aburas

PharmD, BCPS

Senior Clinical Benefit Assessment Specialist

Center for National Health Insurance (CNHI), KSA

Scientific Committee Chair

Hajer Al-Mudaiheem

Board Member

Saudi Society of Clinical Pharmacy (SSCP), KSA

Elevate your brand and connect with key decision-makers at Saudi Arabia's premier healthcare conference.

Sponsor SAHARA+ Conference to gain targeted exposure, build valuable connections, and support innovation in the region's dynamic healthcare sector.

Discover more about the SAHARA+ experience

Strategic Partner

An Initiative By

Follow our socials

© SAHARA+ Conference 2026. All Rights Reserved.